THE DISTRIBUTION OF OESTRADIOL IN PLASMA IN RELATION TO UTERINE CROSS‐SECTIONAL AREA IN WOMEN WITH POLYCYSTIC OR MULTIFOLLICULAR OVARIES

The uterine cross‐sectional area (UXA) of women with polycystic (PCO) or multifollicular ovaries (MFO) is significantly larger and smaller, respectively, than those of normal women during the early‐mid‐follicular phase of the menstrual cycle. In the present study the distribution of oestradiol in plasma from normal women and women with PCO or MFO was measured to determine if differences in the available fractions of oestradiol could account for the differences in UXA of women with PCO or MFO. No differences in plasma levels of oestradiol were detected and the concentrations of oestradiol present in a free state or bound to albumin were similar in normal women and women with PCO or MFO. The concentration of oestrone was significantly higher in plasma from women with PCO (516 ± 120 pmo1/1, mean ± SD) than in plasma from women with MFO (389 ± 91 pmo1/1) or normal women (376 ± 89 pmo1/1). Differences in UXA for women with PCO or MFO as compared with normal women cannot therefore be attributed to differences in available oestradiol concentrations. It is possible that abnormalities in oestrogen metabolism within uterine or other tissues may account for the UXA of women with PCO or MFO. Increased plasma oestrone levels in women with PCO may provide more substrate for conversion to oestradiol within the uterus whilst the smaller UXA of women with MFO may reflect both lack of normal cyclical increases of oestradiol and formation of biologically inactive oestradiol metabolites.

[1]  M. Ghilchik,et al.  A comparison of the in vivo uptake and metabolism of 3H‐oestrone and 3H‐oestradiol by normal breast and breast tumour tissues in post‐menopausal women , 1986, International journal of cancer.

[2]  M. Ghilchik,et al.  The effect of epidermal growth factor, transforming growth factor and breast tumour homogenates on the activity of oestradiol 17 beta hydroxysteroid dehydrogenase in cultured adipose tissue. , 1986, Cancer letters.

[3]  M. Reed,et al.  Free fatty acids: a possible regulator of the available oestradiol fractions in plasma. , 1986, Journal of steroid biochemistry.

[4]  J. Price,et al.  MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE , 1985, The Lancet.

[5]  M. Reed,et al.  Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. , 1983, Cancer research.

[6]  L. Tseng,et al.  Estrogen synthesis in normal and malignant human endometrium. , 1982, The Journal of clinical endocrinology and metabolism.

[7]  F. Naftolin,et al.  Comparative pharmacology of oestrogens and catechol oestrogens: actions on the immature rat uterus in vivo and in vitro. , 1982, The Journal of endocrinology.

[8]  P. Baxendale,et al.  Changes in plasma concentrations of oestrogens and progesterone in women during anaesthesia and gynaecological operations. , 1981, Journal of steroid biochemistry.

[9]  B. J. Davidson,et al.  Effects of human serum on transport of testosterone and estradiol into rat brain. , 1980, The American journal of physiology.

[10]  S. C. Yen,et al.  REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME , 1980 .

[11]  J. Shepherd,et al.  TRANSPLACENTAL GRADIENTS OF SEX‐HORMONE‐BINDING GLOBULIN IN HUMAN AND SIMIAN PREGNANCY , 1976, Clinical endocrinology.

[12]  L. Hellman,et al.  Influence of body weight on estradiol metabolism in young women. , 1975, The Journal of clinical endocrinology and metabolism.

[13]  E. Gurpide,et al.  Induction of human endometrial estradiol dehydrogenase by progestins. , 1975, Endocrinology.

[14]  R. Tremblay,et al.  Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. , 1974, Contraception.

[15]  H. Baker,et al.  The measurement of sex steroid binding globulin by differential ammonium sulphate precipitation. , 1973, Journal of steroid biochemistry.

[16]  W. Rosner.  A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma. , 1972, The Journal of clinical endocrinology and metabolism.

[17]  J. Thijssen,et al.  In vivo uptake and subcellular distribution of tritium-labeled estrogens in human endometrium, myometrium, and vagina. , 1983, The Journal of clinical endocrinology and metabolism.

[18]  M. Reed,et al.  Inhibition of 17 beta-hydroxysteroid dehydrogenase activity in human endometrium by adrenal androgens. , 1983, Journal of steroid biochemistry.

[19]  D. Mishell,et al.  Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. , 1981, The Journal of clinical endocrinology and metabolism.